vs
Arbutus Biopharma Corp(ABUS)与High Roller Technologies, Inc.(ROLR)财务数据对比。点击上方公司名可切换其他公司
Arbutus Biopharma Corp的季度营收约是High Roller Technologies, Inc.的1.7倍($10.7M vs $6.3M),High Roller Technologies, Inc.净利率更高(58.4% vs 23.5%,领先34.9%),Arbutus Biopharma Corp同比增速更快(522.2% vs -16.4%)
Arbutus生物制药是一家公开上市的加拿大生物制药企业,专长于脂质体药物递送与RNA干扰技术,目前主要开展针对乙型肝炎感染的治疗药物研发工作,在抗病毒新药研发领域拥有深厚的技术积累。
该企业主营游乐设施业务,凭借气动驱动技术打造各类游乐设备,专业从事过山车设计研发,在游乐设施设计制造领域拥有相关技术积累与行业经验。
ABUS vs ROLR — 直观对比
营收规模更大
ABUS
是对方的1.7倍
$6.3M
营收增速更快
ABUS
高出538.6%
-16.4%
净利率更高
ROLR
高出34.9%
23.5%
损益表 — Q2 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $10.7M | $6.3M |
| 净利润 | $2.5M | $3.7M |
| 毛利率 | — | — |
| 营业利润率 | 13.9% | 1.3% |
| 净利率 | 23.5% | 58.4% |
| 营收同比 | 522.2% | -16.4% |
| 净利润同比 | 112.7% | 831.9% |
| 每股收益(稀释后) | $0.01 | $0.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ABUS
ROLR
| Q3 25 | — | $6.3M | ||
| Q2 25 | $10.7M | $6.9M | ||
| Q1 25 | — | $6.8M | ||
| Q3 24 | — | $7.5M | ||
| Q4 23 | $2.1M | — | ||
| Q3 23 | $4.7M | — | ||
| Q2 23 | $4.7M | — | ||
| Q1 23 | $6.7M | — |
净利润
ABUS
ROLR
| Q3 25 | — | $3.7M | ||
| Q2 25 | $2.5M | $-592.0K | ||
| Q1 25 | — | $-3.3M | ||
| Q3 24 | — | $-501.0K | ||
| Q4 23 | — | — | ||
| Q3 23 | $-20.1M | — | ||
| Q2 23 | $-17.1M | — | ||
| Q1 23 | $-16.3M | — |
营业利润率
ABUS
ROLR
| Q3 25 | — | 1.3% | ||
| Q2 25 | 13.9% | -7.2% | ||
| Q1 25 | — | -47.4% | ||
| Q3 24 | — | -6.3% | ||
| Q4 23 | -967.2% | — | ||
| Q3 23 | -462.8% | — | ||
| Q2 23 | -395.3% | — | ||
| Q1 23 | -260.4% | — |
净利率
ABUS
ROLR
| Q3 25 | — | 58.4% | ||
| Q2 25 | 23.5% | -8.5% | ||
| Q1 25 | — | -48.4% | ||
| Q3 24 | — | -6.7% | ||
| Q4 23 | — | — | ||
| Q3 23 | -431.6% | — | ||
| Q2 23 | -367.5% | — | ||
| Q1 23 | -244.3% | — |
每股收益(稀释后)
ABUS
ROLR
| Q3 25 | — | $0.39 | ||
| Q2 25 | $0.01 | $-0.07 | ||
| Q1 25 | — | $-0.39 | ||
| Q3 24 | — | $-0.07 | ||
| Q4 23 | $-0.12 | — | ||
| Q3 23 | $-0.12 | — | ||
| Q2 23 | $-0.10 | — | ||
| Q1 23 | $-0.10 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $37.4M | $2.7M |
| 总债务越低越好 | $0 | — |
| 股东权益账面价值 | $83.0M | $6.6M |
| 总资产 | $103.3M | $16.0M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势,按日历期对齐
现金及短期投资
ABUS
ROLR
| Q3 25 | — | $2.7M | ||
| Q2 25 | $37.4M | $2.7M | ||
| Q1 25 | — | $3.5M | ||
| Q3 24 | — | $1.3M | ||
| Q4 23 | $126.0M | — | ||
| Q3 23 | $17.5M | — | ||
| Q2 23 | $27.2M | — | ||
| Q1 23 | $40.6M | — |
总债务
ABUS
ROLR
| Q3 25 | — | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q4 23 | $0 | — | ||
| Q3 23 | $0 | — | ||
| Q2 23 | $0 | — | ||
| Q1 23 | $0 | — |
股东权益
ABUS
ROLR
| Q3 25 | — | $6.6M | ||
| Q2 25 | $83.0M | $2.6M | ||
| Q1 25 | — | $2.8M | ||
| Q3 24 | — | $-779.0K | ||
| Q4 23 | $106.0M | — | ||
| Q3 23 | $119.3M | — | ||
| Q2 23 | $134.7M | — | ||
| Q1 23 | $143.9M | — |
总资产
ABUS
ROLR
| Q3 25 | — | $16.0M | ||
| Q2 25 | $103.3M | $12.3M | ||
| Q1 25 | — | $12.8M | ||
| Q3 24 | — | $12.9M | ||
| Q4 23 | $144.4M | — | ||
| Q3 23 | $158.6M | — | ||
| Q2 23 | $176.8M | — | ||
| Q1 23 | $191.2M | — |
负债/权益比
ABUS
ROLR
| Q3 25 | — | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q4 23 | 0.00× | — | ||
| Q3 23 | 0.00× | — | ||
| Q2 23 | 0.00× | — | ||
| Q1 23 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-15.7M | $-78.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-90.0K |
| 自由现金流率自由现金流/营收 | — | -1.4% |
| 资本支出强度资本支出/营收 | 0.0% | 0.2% |
| 现金转化率经营现金流/净利润 | -6.24× | -0.02× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ABUS
ROLR
| Q3 25 | — | $-78.0K | ||
| Q2 25 | $-15.7M | $-840.0K | ||
| Q1 25 | — | $-3.6M | ||
| Q3 24 | — | — | ||
| Q4 23 | $-17.3M | — | ||
| Q3 23 | $-21.8M | — | ||
| Q2 23 | $-19.6M | — | ||
| Q1 23 | $-27.3M | — |
自由现金流
ABUS
ROLR
| Q3 25 | — | $-90.0K | ||
| Q2 25 | — | $-845.0K | ||
| Q1 25 | — | $-3.6M | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-21.8M | — | ||
| Q2 23 | $-20.4M | — | ||
| Q1 23 | $-27.4M | — |
自由现金流率
ABUS
ROLR
| Q3 25 | — | -1.4% | ||
| Q2 25 | — | -12.2% | ||
| Q1 25 | — | -53.5% | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -468.4% | — | ||
| Q2 23 | -439.0% | — | ||
| Q1 23 | -410.0% | — |
资本支出强度
ABUS
ROLR
| Q3 25 | — | 0.2% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q3 24 | — | — | ||
| Q4 23 | 0.0% | — | ||
| Q3 23 | 0.7% | — | ||
| Q2 23 | 18.5% | — | ||
| Q1 23 | 1.7% | — |
现金转化率
ABUS
ROLR
| Q3 25 | — | -0.02× | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABUS
暂无分部数据
ROLR
| Net Gaming Revenue | $4.9M | 77% |
| Net Revenue Noncore Services | $1.4M | 23% |